This review outlines decision strategies for modifying standard enoxaparin treatment protocols to optimize effectiveness and safety in complex clinical situations like renal dysfunction and elderly age.
How can the effectiveness and safety of enoxaparin therapy be improved in patients with cardiovascular diseases and complex clinical situations?
This review provides decision strategies for modifying standard enoxaparin treatment protocols in complex clinical scenarios to optimize effectiveness and safety.
The review analyses the specifics of enoxaparin therapy in the most prevalent cardiovascular diseases, such as acute coronary syndrome, venous thromboembolism, and atrial fibrillation. The decision strategy is presented for difficult and non-standard clinical situations (renal dysfunction, elderly age, heparin medication change, or abnormal body weight), when the optimal balance between effectiveness and safety requires modifying the standard treatment protocols.
I. S. Yavelov (Tue,) conducted a review in Cardiovascular diseases (acute coronary syndrome, venous thromboembolism, atrial fibrillation). Enoxaparin was evaluated. This review outlines decision strategies for modifying standard enoxaparin treatment protocols to optimize effectiveness and safety in complex clinical situations like renal dysfunction and elderly age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: